Ferraccioli G - Search Results

1

Ferraccioli G, Gremese E, Goletti D, Petrone L, Cantini F, Ugel S, Canè S, Bronte V. Ferraccioli G, et al. Cancer Immunol Res. 2022 Apr 1;10(4):384-402. doi: 10.1158/2326-6066.CIR-21-0675. Cancer Immunol Res. 2022. PMID: 35074758

2

Cyclosporine A pharmacokinetics in rheumatoid arthritis patients after 6 months of methotrexate therapy.

Baraldo M, Ferraccioli G, Pea F, Gremese E, Furlanut M. Baraldo M, et al. Among authors: ferraccioli g. Pharmacol Res. 1999 Dec;40(6):483-6. doi: 10.1006/phrs.1999.0539. Pharmacol Res. 1999. PMID: 10660945

3

Residual minimal disease activity in rheumatoid arthritis: a simple definition through an in-depth statistical analysis of the major outcome.

Pietrapertosa D, Salaffi F, Peluso G, Bosello SL, Fedele AL, Cuoghi I, Michelutti A, Gremese E, Ferraccioli GF. Pietrapertosa D, et al. Among authors: ferraccioli gf. Rheumatology (Oxford). 2009 Oct;48(10):1242-6. doi: 10.1093/rheumatology/kep217. Epub 2009 Jul 27. Rheumatology (Oxford). 2009. PMID: 19635732

4

Association between the response to B cell depletion therapy and the allele*2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients.

Canestri S, Totaro MC, Serone E, Tolusso B, Frezza D, Gremese E, Ferraccioli G. Canestri S, et al. Among authors: ferraccioli g. Reumatismo. 2012 Dec 20;64(6):368-73. doi: 10.4081/reumatismo.2012.368. Reumatismo. 2012. PMID: 23285480

5

Disease-modifying Antirheumatic Drugs (DMARD) and Combination Therapy of Conventional DMARD in Patients with Spondyloarthritis and Psoriatic Arthritis with Axial Involvement.

Simone D, Nowik M, Gremese E, Ferraccioli GF. Simone D, et al. J Rheumatol Suppl. 2015 Nov;93:65-9. doi: 10.3899/jrheum.150640. J Rheumatol Suppl. 2015. PMID: 26523061 Review.

6

The role of high-mobility group box protein 1 in collagen antibody-induced arthritis is dependent on vascular endothelial growth factor.

Biscetti F, Flex A, Pecorini G, Angelini F, Arena V, Stigliano E, Gremese E, Tolusso B, Ferraccioli G. Biscetti F, et al. Among authors: ferraccioli g. Clin Exp Immunol. 2016 Apr;184(1):62-72. doi: 10.1111/cei.12758. Epub 2016 Jan 19. Clin Exp Immunol. 2016. PMID: 26671547 Free PMC article.

7

B cell activating factor (BAFF) and BAFF receptors: fakes and facts.

Ferraccioli G, Gremese E. Ferraccioli G, et al. Clin Exp Immunol. 2017 Dec;190(3):291-292. doi: 10.1111/cei.13039. Epub 2017 Sep 28. Clin Exp Immunol. 2017. PMID: 28834574 Free PMC article. Review.

8

The Role of High-Mobility Group Box-1 and Its Crosstalk with Microbiome in Rheumatoid Arthritis.

Biscetti F, Flex A, Alivernini S, Tolusso B, Gremese E, Ferraccioli G. Biscetti F, et al. Among authors: ferraccioli g. Mediators Inflamm. 2017;2017:5230374. doi: 10.1155/2017/5230374. Epub 2017 Oct 23. Mediators Inflamm. 2017. PMID: 29200665 Free PMC article. Review.

9

Driving chronicity in rheumatoid arthritis: perpetuating role of myeloid cells.

Alivernini S, Tolusso B, Ferraccioli G, Gremese E, Kurowska-Stolarska M, McInnes IB. Alivernini S, et al. Among authors: ferraccioli g. Clin Exp Immunol. 2018 Jul;193(1):13-23. doi: 10.1111/cei.13098. Epub 2018 Feb 2. Clin Exp Immunol. 2018. PMID: 29315512 Free PMC article. Review.

10

Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy.

Fedele AL, Petricca L, Tolusso B, Alivernini S, Canestri S, Di Mario C, Bosello SL, Ferraccioli G, Gremese E. Fedele AL, et al. Among authors: ferraccioli g. Scand J Rheumatol. 2018 Sep;47(5):351-359. doi: 10.1080/03009742.2017.1416668. Epub 2018 Mar 15. Scand J Rheumatol. 2018. PMID: 29542372

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

469 results

Search Page